1Blumberg B S. Australia antigen and the biology of hepatitis B[J].Science,1977,197(4298):17-25.
2Krugman S, Giles J P, Hammond J. Infectious hepatitis.Evidence for two distinctive clinical, epidemiological, and immunological types of infection[J]. JAMA,1967,200(5):365-373.
3Su T H,Hsu C S,Chen C L,et al.Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B[J].Antivir Ther,2010,15(8):1131-1139.
4Ma H,Yang R F,Wei L.Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa2b in HBeAgpositive patients.[J] J Gastroenterol Hepatol,2010,25(9):1498-1506.
5Yu J. Kim, Hyun C,et al.The change of the quantitative HBsAg level during the natural course of chronic hepatitis B[J].Liver International,2011,31(6),817-823.
6Lau G K, Marcellin P, Brunetto M R,et al. Ontreatment HBsAg decline during peginterferon alfa2a (40 KD) ± lamivudine in patients with HBeAgpositive CHB as a potential predictor of durable offtreatment response[J].Hepatology,2008, 48(Suppl 1):714A.
7Kimura T, Rokuhara A, Matsumoto A, et al.New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA[J].J Clin Microbiol,2003,41(5):1901-1906.
8Liu F, Campagna M, Qi Y, et al. Alphainterferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes[J]. PLoS Pathogens, 2013, 9(9): e1003613.
9WerleLapostolle B, Bowden S, Locarnini S, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy[J]. Gastroenterology, 2004, 126(7): 1750-1758.
10Palumbo G A, Belloni L, Valente S, et al. OC-22 suppression of HBV transcription and replication by small molecules that target the epigenetic control of nuclear cccDNA minichromosome[J]. Dig Liver Dis,2013,45:S8.
2FEITELSON M A, SUN B, LIU J, et al. Genetic mechanisms of hepatocarcinogenesis[ J]. Oncogene, 2002, 21 (16) : 2593-2604.
3CHIU CM, YEH SH, CHEN P J, et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level[J]. PNAS, 2007, 104(8) : 2571-2578.
4PISANI P, PARKIN D M, BRAY F, et al. Estimates of the worldwide mortality from 25 cancers in 1990[J]. Int J Cancer, 1999, 83(1): 18-29.
5SU J M, LAI X M, LANK H, et al. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter[J]. Hepatology, 2007, 46(2) : 402-413.
6BOUCHARD M J, SCHNEIDER R J. The enigmatic X gene of hepatitis B virus[J]. J Virol, 2004, 78(23) : 12725-12734.
7CHEONG J H, YI M, LIN Y, et al. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation [J]. EMBOJ, 1995, 14(1): 143-150.
8QADRI I, MAGUIRE H F, SIDDIQUI A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein [ J ]. Proc Natl Acad Sci U S A, 1996, 93 (20) : 10578-10583.
9LIVAK K J, SCHMITTGEN TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method[J]. Methods, 2001, 25(4): 402-408.
10SHIH Y L, SHYU R Y, HSIEH C B, et al. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma[ J ]. Cancer, 2006, 107 (3) : 579-590.
